many times the total amount a patient would receive weekly from this injection
Each year, an estimated 300,000 adults in the United States die of causes related to obesity [2] According to the guidelines of the National Institute of Health (NIH) regarding the treatment of obesity, weight loss drugs approved by the FDA [US Food and Drug Administration] may only be used as part of a comprehensive weight loss program, including dietary therapy and physical activity, for patients with a BMI [body mass index] of 30 with no concomitant obesity-related risk factors or diseases, and for patients with a BMI of 27 with concomitant obesity-related risk factors or diseases[3].The risk factors and diseases considered important enough to warrant pharmacotherapy at a BMI of 27--29.9 are hypertension, dyslipidemia, coronary heart disease (CHD), type 2 diabetes, and sleep apnea [3]
This guide explains how it works, what the evidence shows, nasal spray vs injectable, and who is a candidate for a supervised protocol
Athletes subject to WADA, USADA, NCAA, or any sport-governing-body testing should not use AOD-9604 in any form
Any third-party brands or services referenced on this site are included for informational purposes only